ImmunityBio (IBRX) EBT Margin Growth (1y) (2015 - 2026)
Powered by 
Analysis
ImmunityBio (IBRX) EBT Margin Growth (1y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 553.00 |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 4,709.00 |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 1,076.00 |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 1,911.00 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | -392.00 |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 29,565.00 |
| 10 | ImmunityBio | 8.45 Bn | 8.10 Bn | 50.94 Mn | -10,032.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10,032.00 |
| Mar 31, 2026 | -64,499.00 |
| Dec 31, 2025 | 62,143.00 |
| Sep 30, 2025 | 119,445.00 |
| Jun 30, 2025 | 1.25 Mn |
| Mar 31, 2025 | 33.45 Mn |
| Dec 31, 2024 | 16.72 Mn |
| Sep 30, 2024 | 11.52 Mn |
| Jun 30, 2024 | 32.43 Mn |
| Mar 31, 2024 | -30.29 Mn |
| Dec 31, 2023 | -1.96 Mn |
| Sep 30, 2023 | -2.24 Mn |
| Jun 30, 2023 | -6.61 Mn |
| Mar 31, 2023 | 70.33 Mn |
| Dec 31, 2022 | -12.49 Mn |
| Sep 30, 2022 | 3.98 Mn |
| Jun 30, 2022 | -24.46 Mn |
| Mar 31, 2022 | -67.78 Mn |
| Dec 31, 2021 | 30.41 Mn |
| Sep 30, 2021 | -8.90 Mn |